EXERCISE DURING ADJUVANT CANCER TREATMENT DECREASED NAUSEA AT THE END OF TREATMENT IN BREAST CANCER PATIENTS

2.50
Hdl Handle:
http://hdl.handle.net/10755/165039
Category:
Abstract
Type:
Presentation
Title:
EXERCISE DURING ADJUVANT CANCER TREATMENT DECREASED NAUSEA AT THE END OF TREATMENT IN BREAST CANCER PATIENTS
Author(s):
Lee, Jiyeon; Dodd, Marylin
Author Details:
Jiyeon Lee, RN. MS., Doctoral Student, Research Assistant, University of California San Francisco, San Francisco, California, USA, email: jiyeon.lee@ucsf.edu; Marylin Dodd, RN, PhD, FAAN
Abstract:
Exercise has been suggested as an effective intervention for cancer related symptoms such as fatigue and sleep. However, only a few studies have been done that focused on the effect of exercise in nausea control, with inconclusive results. The purpose of this study was to evaluate the effect of exercise in nausea control during and after adjuvant chemotherapy (CTx) + Radiation therapy (RTx). The theoretical framework of this study is the model for symptom management. This secondary data analysis is based on randomized clinical trial that investigated the effect of exercise on fatigue of cancer patients. Subjects were female breast cancer patients with stage I to III (N=112). Most subjects received adriamycin and cyclophosphamide (n=98) + RTx (n=59). Subjects completed baseline measurement (T1) between the completion of the first cycle and before the start of second cycle of CTx. Second measurement was done after completion of all cycles of CTx + RTx (T2). The final measurement was completed after equivalent period of time between T1 and T2 (T3). Exercise status was measured by intensity of exercise, time per each session, and the number days per week. If a subject exercised somewhat hard in intensity, more than 21 minutes per session and more than three days per week, the subject was considered as an exerciser. Patients evaluated nausea severity on a 0-10 numeric rating scale. Mann-Whitney U test was used to compare mean nausea severity between exercisers (n=45) and non-exercisers (n=52). There was significant difference in nausea severity between exerciser and non-exerciser at T2 (z=-2.183, p=.029). For subjects who were exercisers at T1, continuation of exercise during treatment phase (T1-T2) is emphasized, since discontinuing exercise resulted in more nausea after their treatment (T2). Starting exercise with adjuvant therapy (T1-T2) in non- exercisers at T1 is highly recommended as to achieve better control of nausea after the treatment (T2). Encouraging subjects to exercise during adjuvant therapy is a suggested intervention to control nausea after therapy.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2007
Conference Name:
32nd Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Las Vegas, Nevada, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleEXERCISE DURING ADJUVANT CANCER TREATMENT DECREASED NAUSEA AT THE END OF TREATMENT IN BREAST CANCER PATIENTSen_GB
dc.contributor.authorLee, Jiyeonen_US
dc.contributor.authorDodd, Marylinen_US
dc.author.detailsJiyeon Lee, RN. MS., Doctoral Student, Research Assistant, University of California San Francisco, San Francisco, California, USA, email: jiyeon.lee@ucsf.edu; Marylin Dodd, RN, PhD, FAANen_US
dc.identifier.urihttp://hdl.handle.net/10755/165039-
dc.description.abstractExercise has been suggested as an effective intervention for cancer related symptoms such as fatigue and sleep. However, only a few studies have been done that focused on the effect of exercise in nausea control, with inconclusive results. The purpose of this study was to evaluate the effect of exercise in nausea control during and after adjuvant chemotherapy (CTx) + Radiation therapy (RTx). The theoretical framework of this study is the model for symptom management. This secondary data analysis is based on randomized clinical trial that investigated the effect of exercise on fatigue of cancer patients. Subjects were female breast cancer patients with stage I to III (N=112). Most subjects received adriamycin and cyclophosphamide (n=98) + RTx (n=59). Subjects completed baseline measurement (T1) between the completion of the first cycle and before the start of second cycle of CTx. Second measurement was done after completion of all cycles of CTx + RTx (T2). The final measurement was completed after equivalent period of time between T1 and T2 (T3). Exercise status was measured by intensity of exercise, time per each session, and the number days per week. If a subject exercised somewhat hard in intensity, more than 21 minutes per session and more than three days per week, the subject was considered as an exerciser. Patients evaluated nausea severity on a 0-10 numeric rating scale. Mann-Whitney U test was used to compare mean nausea severity between exercisers (n=45) and non-exercisers (n=52). There was significant difference in nausea severity between exerciser and non-exerciser at T2 (z=-2.183, p=.029). For subjects who were exercisers at T1, continuation of exercise during treatment phase (T1-T2) is emphasized, since discontinuing exercise resulted in more nausea after their treatment (T2). Starting exercise with adjuvant therapy (T1-T2) in non- exercisers at T1 is highly recommended as to achieve better control of nausea after the treatment (T2). Encouraging subjects to exercise during adjuvant therapy is a suggested intervention to control nausea after therapy.en_GB
dc.date.available2011-10-27T12:11:26Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:11:26Z-
dc.conference.date2007en_US
dc.conference.name32nd Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationLas Vegas, Nevada, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.